News + Filings Transactions Holdings
All
13F
13D/G
Other
|
|
Pivotal bioVenture Partners Fund I, L.P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
SC 13D/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 9.5% stake in Inozyme Pharma, Inc. |
| 05/23/2023 |
SC 13D/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 8.3% stake in Inozyme Pharma, Inc. |
| 04/04/2023 |
SC 13D/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 7.4% stake in Inozyme Pharma, Inc. |
| 03/15/2023 |
SC 13G
| Pivotal bioVenture Partners Fund I, L.P. reports a 9.3% stake in Oculis Holding AG |
| 08/25/2022 |
SC 13G/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 4.9% stake in Akouos, Inc. |
| 04/28/2022 |
SC 13D
| Pivotal bioVenture Partners Fund I, L.P. reports a 6.6% stake in Inozyme Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 6.7% stake in Inozyme Pharma, Inc. |
| 02/14/2022 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/13/2021 |
SC 13D/A
| Pivotal bioVenture Partners Fund I, L.P. reports a 8.4% stake in Bolt Biotherapeutics, Inc. |
| 08/12/2021 |
SC 13D
| Pivotal bioVenture Partners Fund I, L.P. reports a 7.3% stake in Rallybio Corporation |
| 02/17/2021 |
SC 13D
| Pivotal bioVenture Partners Fund I, L.P. reports a 5.5% stake in Bolt Biotherapeutics, Inc. |
| 02/09/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/09/2021 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
| 02/09/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 08/04/2020 |
SC 13D
| Form SC 13D - General statement of acquisition of beneficial ownership: |
| 07/10/2020 |
SC 13D
| Pivotal bioVenture Partners Fund I, L.P. reports a 5.5% stake in Akouos, Inc. |
|
|